Senior Medical Director Clinical Development, Amyloidosis and Rare Cardiology

The Senior Medical Director Clinical Development will lead the clinical team for a high-visibility program and report to the Global Clinical Head. This is an excellent opportunity for an experienced and motivated drug developer to advance an innovative, late-stage ATTR amyloidosis study. 

The SD will provide medical leadership across all stages of clinical development, from IND/CTA and First-in-Human through Proof-of-Concept and End-of-Phase 2 and beyond. Acting as a key medical expert on the study team(s), the SD may also serve as medical monitor as needed. 

In this role, the SD will work cross-functionally and mentor Physicians, Clinical Directors, and Clinical Development Scientists. The position may include direct and indirect managerial responsibilities for team members across the Clinical Development organization. The SD will also contribute to the development of regulatory, therapeutic area, and functional strategies. 

This position offers the opportunity to collaborate closely with enterprise-level, cross-functional teams, including AstraZeneca Business Units, CVRM, and strategic development partners. The ideal candidate will thrive in a fast-paced, proactive, and collaborative culture—demonstrating strong communication skills, scientific leadership, and the ability to drive impact across both internal and external teams. 

You will be responsible for:  

• Lead cross-functional clinical program teams to deliver high-quality studies and research strategies, ensuring scientific rigor and optimal benefit–risk management. 

• Serve as the clinical authority for assigned programs, overseeing study design, execution, data interpretation, and regulatory deliverables in compliance with GCP. 

• Provide strategic medical and scientific input across R&D, translational science, commercial, and business development activities, including due diligence and collaborations. 

• Mentor and develop Medical Directors, Clinical Development Scientists, and fellows to build organizational scientific and leadership capability. 

• Monitor and interpret evolving scientific, clinical, and competitive intelligence in ATTR amyloidosis to inform program strategy and innovation. 

• Represent the program internally and externally through governance presentations, regulatory interactions, scientific publications, and engagement with key opinion leaders. 

You will need to have: 

• MD with specialty training in Cardiology or Internal Medicine. 

• 7+ years of experience in clinical development; clinical research, global regulatory, and product development expertise   

• Has prepared documents and attended regulatory meetings with FDA and other regulatory agencies. 

• Experience designing and executing multinational clinical trials required 

• Demonstrated ability to lead cross-functional teams to define clinical strategy and clinical study design. 

• Experience supporting business development activities. 

• Ability to learn rapidly, think critically, and operate effectively in a fast-paced environment. 

• The duties of this role are generally conducted in an office environment. As is typical of an office-based role, employees must be able, with or without an accommodation to: use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving and non-linear thought, analy